With 26% Growth in H1, Neimeth Outshines Peers in Revenue Generation

Neimeth International Pharmaceuticals Plc reported a 26 per cent year-on-year increase in revenue in the first half of 2026. The company was identified as the fastest-growing listed pharmaceutical company by revenue during the period, making the update relevant to investors tracking its earnings and the healthcare sector.